Items where Author is "Sharrack, Basil"
Jump to: Article
Number of items: 10.
Article
BRITTAIN, Gavin, PETRIE, Jennifer, DUFFY, Kate E. M., GLOVER, Rachel, HULLOCK, Katie, PAPAIOANNOU, Diana, ROLDAN, Elisa, BEECHER, Colette, BURSNALL, Matthew, CICCARELLI, Olga, COLES, Alasdair J., COOPER, Cindy, GIOVANNONI, Gavin, GABRIEL, Ian, KAZMI, Majid, KYRIAKOU, Charalampia, NICHOLAS, Richard, PALING, David, PENIKET, Andy, SCOLDING, Neil, SILBER, Eli, DE SILVA, Thushan, VENNERI, Annalena, WALTERS, Stephen J., YOUNG, Carolyn, MURARO, Paolo A., SHARRACK, Basil, SNOWDEN, John A., PUBLICOVER, Amy, CLARK, Andy, BEN TURNER, Caroline Besley, KYRIAKOU, Charalampia, CRAWLEY, Charles, RICE, Claire, HUNT, David, ROG, David, THOLOULI, Eleni, NIKFEKR, Esmaeil, KINSELLA, Fran, LUCA, Gabriele De, MAZIBRADA, Gordon, HUNTER, Hannah, POMEROY, Ian, DAVIES, Jeff, BYRNE, Jenny, HOBART, Jeremy, CAMPBELL, Keith, ORCHARD, Kim, FINISKU, Leonora, DUDDY, Martin, VINJAM, Maruthi, SAIF, Muhammad, ROBERTSON, Neil, CICCARELLI, Olga, GALLAGHER, Paul, BULLEY, Simon, CAMPBELL, Vic and ISMAIL, Azza
(2024).
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
BMJ Open, 14 (2).
[Article]
HOLDEN, David W, GOLD, Julian, HAWKES, Christopher H, GIOVANNONI, Gavin, SAXTON, John M., CARTER, Anouska and SHARRACK, Basil
(2018).
Epstein Barr virus shedding in multiple sclerosis: similar frequencies of EBV in saliva across separate patient cohorts.
Multiple Sclerosis and Related Disorders, 25, 197-199.
[Article]
RAMOS, Ines, LYNG, Fiona M., REHMAN, Ihtesham Ur, SHARRACK, Basil and WOODROOFE, Nicola
(2017).
The use of vibrational spectroscopy to study the pathogenesis multiple sclerosis and other neurological conditions.
Applied Spectroscopy Reviews, 52.
[Article]
CRANK, Helen, CARTER, Anouska, HUMPHREYS, Liam, SNOWDON, Nicky, DALEY, Amanda, WOODROOFE, Nicola, SHARRACK, Basil, PETTY, Jane and SAXTON, John M.
(2017).
A qualitative investigation of exercise perceptions and experiences in people with multiple sclerosis before, during and after participation in a personally-tailored exercise program.
Archives of Physical Medicine and Rehabilitation, 98 (12), 2520-2525.
[Article]
WALLER, Rachel, WOODROOFE, Nicola, WHARTON, Stephen B., INCE, Paul G., FRANCESE, Simona, HEATH, Paul R., CUDZICH-MADRY, A, THOMAS, Ruth, ROUNDING, Natalie, SHARRACK, Basil and SIMPSON, Julie E.
(2016).
Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role.
Journal of Neuroimmunology, 299, 139-146.
[Article]
CARTER, Anouska, HUMPHREYS, Liam, SNOWDON, Nicky, SHARRACK, Basil, DALEY, Amanda, PETTY, Jane, WOODROOFE, Nicola and SAXTON, John
(2015).
Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis.
Trials, 16 (1).
[Article]
CARTER, Anouska M., DALEY, Amanda J., KESTERTON, Sue W., WOODROOFE, Nicola, SAXTON, John M. and SHARRACK, Basil
(2013).
Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: A randomised controlled feasibility study.
Contemporary Clinical Trials, 35 (2), 40-47.
[Article]
HURST, Louise A., BUNNING, Rowena, SHARRACK, Basil and WOODROOFE, Nicola
(2012).
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
Neuroscience Letters, 521, 52-56.
[Article]
HURST, Louise A., BUNNING, Rowena A.D., SHARRACK, Basil and WOODROOFE, M. Nicola
(2012).
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
Neuroscience Letters, 521 (1), 52-56.
[Article]
BRADFORD, C M, CROSS, Alison, HADDOCK, Gail, WOODROOFE, Nicola Woodroofe and SHARRACK, Basil
(2011).
Citrullination of CNS proteins in the pathogenesis of multiple sclerosis.
Future Neurology, 6 (4), 521-530.
[Article]